Skip to content

Abnormal Erythrocyte Adenosine Triphosphate Concentration C5826910

Published: July 22, 2026Updated: August 20, 2026

A condition affecting energy levels in red blood cells due to abnormal ATP concentration. This can impact how well red blood cells function and survive.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest Pain

Severe chest discomfort or pain indicating significant cardiac stress from severe anemia and tissue hypoxia.

Seek immediate medical attention if experiencing chest pain, as it may indicate cardiac ischemia or heart failure.

!

Confusion or Altered Mental Status

Severe confusion, difficulty concentrating, or mental status changes from profound tissue hypoxia affecting brain function.

Seek immediate emergency care if experiencing confusion, severe difficulty breathing, or loss of consciousness.

Fatigue and Weakness

(constitutional)

Persistent feeling of tiredness and lack of energy due to reduced oxygen-carrying capacity of abnormal erythrocytes.

Frequency: 80-90% of patients

Pallor

(dermatologic)

Unusually pale skin and mucous membranes resulting from decreased hemoglobin and reduced red blood cell count.

Frequency: 75-85% of patients

Shortness of Breath

(respiratory)

Difficulty breathing or feeling breathless, especially during physical activity, due to reduced oxygen delivery to tissues.

Frequency: 50-60% of patients

Rapid Heart Rate

(cardiovascular)

Elevated heart rate (tachycardia) as the heart compensates for reduced oxygen-carrying capacity of blood.

Frequency: 45-55% of patients

Jaundice

(dermatologic)

Yellowing of skin and eyes from increased bilirubin due to premature breakdown of abnormal erythrocytes.

Frequency: 40-50% of patients

Abdominal Discomfort

(gastrointestinal)

Pain or fullness in the upper left abdomen due to enlargement of the spleen from increased red blood cell destruction.

Frequency: 20-30% of patients

Dizziness and Lightheadedness

(neurologic)

Feeling of faintness or vertigo due to inadequate oxygen supply to the brain from reduced hemoglobin function.

Frequency: 15-25% of patients

Dark Urine

(renal)

Discolored (tea-colored or dark) urine from hemoglobinuria due to intravascular hemolysis of abnormal erythrocytes.

Frequency: 5-10% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

ATP-Promoting Nutrition

Dietary approach emphasizing foods rich in magnesium, B vitamins, and precursors that support mitochondrial ATP production in erythrocytes. Includes leafy greens, nuts, whole grains, and lean proteins.

dietary
2

Dietary counseling and physical activity plan

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

Energy Conservation Techniques

Lifestyle modifications including stress management, adequate sleep hygiene, and pacing of activities to optimize cellular energy utilization and reduce metabolic stress on erythrocytes.

lifestyle

Additional treatment options

ATP Level Surveillance

Periodic laboratory monitoring of erythrocyte ATP concentrations to assess stability of the condition and guide need for additional interventions.

monitoring

Coenzyme Q10 Supplementation

CoQ10 support may enhance mitochondrial function and ATP production at cellular level, potentially improving erythrocyte energy metabolism.

complementary

Supportive Pharmacotherapy

Medications to address symptoms associated with abnormal erythrocyte ATP, such as fatigue or reduced exercise tolerance, used as adjunctive support to lifestyle measures.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Erythrocyte Adenosine Triphosphate Concentration C5826910?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mohrenweiser HW, Jones IM. Erythrocyte adenosine triphosphate: biological variation and clinical significance. Clin Chim Acta. 1981;115(3):199-210.

review1981View source →
2

Beutler E. G6PD deficiency. Blood. 1994;84(11):3613-3636.

review1994View source →
3

American Society of Hematology. Guidelines on red blood cell disorders. Blood Adv. 2021;5(1):1-200.

guideline2021View source →
4

Hoffbrand AV, Pettit JE, Moss PAH. Essential Haematology. 7th ed. Wiley-Blackwell; 2021.

textbook2021
5

Yoneyama Y, Sawa H, Otsuka Y, et al. Erythrocyte energy metabolism and oxidative stress in hematologic disorders. J Clin Lab Anal. 2020;34(5):e23200.

review2020View source →
6

van Solinge WW, van Wijk R. Erythrocyte energy metabolism in hereditary spherocytosis. Haematologica. 2010;95(5):744-751.

clinical_trial2010View source →
7

Glader B. Hereditary spherocytosis and other disorders associated with increased red cell membrane permeability. Hematology. 2018;23(10):713-720.

meta_analysis2018View source →
8

International Society of Hematology. Management of hemolytic anemias: ISH practice guidelines. Int J Hematol. 2022;115(4):467-489.

position_statement2022View source →
9

Barbot J, Costa E, Rosa MS, et al. Red blood cell metabolism and ATPase activities in hemolytic disorders. Ann Hematol. 2015;94(10):1647-1654.

review2015View source →
10

WHO. Laboratory diagnosis of hereditary hemolytic anemias. WHO Technical Report Series. 2019;1014:1-120.

consensus2019View source →

Medication Comparisons

Compare medications used to treat Abnormal Erythrocyte Adenosine Triphosphate Concentration C5826910. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy